Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Apr 13;7(8):e007977.
doi: 10.1161/JAHA.117.007977.

Predictors of Mortality and Symptomatic Outcome of Patients With Low-Flow Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement

Norman Mangner  1   2 , Georg Stachel  3 , Felix Woitek  3   2 , Stephan Haussig  2 , Florian Schlotter  3 , Robert Höllriegel  2 , Jennifer Adam  3 , Anna Lindner  3 , Friedrich W Mohr  4 , Gerhard Schuler  3 , Philipp Kiefer  5 , Sergey Leontyev  5 , Michael A Borger  5 , Holger Thiele  3 , David Holzhey  5 , Axel Linke  2
Affiliations

Predictors of Mortality and Symptomatic Outcome of Patients With Low-Flow Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement

Norman Mangner et al. J Am Heart Assoc. .

Abstract

Background: Impaired left ventricular (LV) ejection fraction is a common finding in patients with aortic stenosis and serves as a predictor of morbidity and mortality after transcatheter aortic valve replacement. However, conflicting data on the most accurate measure for LV function exist. We wanted to examine the impact of LV ejection fraction, mean pressure gradient, and stroke volume index on the outcome of patients treated by transcatheter aortic valve replacement.

Methods and results: Patients treated by transcatheter aortic valve replacement were primarily separated into normal flow (NF; stroke volume index >35 mL/m2) and low flow (LF; stroke volume index ≤35 mL/m2). Afterwards, patients were divided into 5 groups: "NF-high gradient," "NF-low gradient" (NF-LG), "LF-high gradient," "paradoxical LF-LG," and "classic LF-LG." The 3-year mortality was the primary end point. Of 1600 patients, 789 (49.3%) were diagnosed as having LF, which was characterized by a higher 30-day (P=0.041) and 3-year (P<0.001) mortality. LF was an independent predictor of all-cause (hazard ratio, 1.29; 95% confidence interval, 1.03-1.62; P=0.03) and cardiovascular (hazard ratio, 1.37; 95% confidence interval, 1.06-1.77; P=0.016) mortality. Neither mean pressure gradient nor LV ejection fraction was an independent predictor of mortality. Patients with paradoxical LF-LG (35.0%), classic LF-LG (35.1%) and LF-high gradient (38.1%) had higher all-cause mortality at 3 years compared with NF-high gradient (24.8%) and NF-LG (27.9%) (P=0.001). However, surviving patients showed a similar improvement in symptoms regardless of aortic stenosis entity.

Conclusions: LF is a common finding within the aortic stenosis population and, in contrast to LV ejection fraction or mean pressure gradient, an independent predictor of all-cause and cardiovascular mortality. Despite increased long-term mortality, high procedural success and excellent functional improvement support transcatheter aortic valve replacement in patients with LF severe aortic stenosis.

Keywords: aortic stenosis; low flow; outcome; transcatheter aortic valve implantation; transcatheter aortic valve replacement.

PubMed Disclaimer

Figures

Figure 1
Figure 1
All‐cause (A) and cardiovascular (B) mortality according to low flow (LF) vs normal flow (NF). HR indicates hazard ratio.
Figure 2
Figure 2
All‐cause (A) and cardiovascular (B) mortality according to mean pressure gradient (MPG). All‐cause (C) and cardiovascular (D) mortality according to left ventricular ejection fraction (LV‐EF). HR indicates hazard ratio.
Figure 3
Figure 3
All‐cause (A) and cardiovascular (B) mortality according to 5 different aortic stenosis entities: normal flow–high gradient (NF‐HG), NF–low gradient (NF‐LG), low flow–HG (LF‐HG), classic LF‐LG (cLF‐LG), and paradoxical LF‐LG (pLF‐LG).
Figure 4
Figure 4
A, Percentage of patients with respective New York Heart Association (NYHA) functional class for each entity at baseline and at 1 year. B, Percentage of patients with NYHA class III or higher for each entity before and after treatment. C, Percentage of patients in each group with NYHA improvement of ≥1 classes after treatment. cLF‐LG indicates classic low flow–low gradient; LF‐HG, low flow–high gradient; NF‐HG, normal flow–high gradient; and pLF‐LG, paradoxical low flow‐low gradient.
See this image and copyright information in PMC

Comment in

References

    1. Herrmann HC, Pibarot P, Hueter I, Gertz ZM, Stewart WJ, Kapadia S, Tuzcu EM, Babaliaros V, Thourani V, Szeto WY, Bavaria JE, Kodali S, Hahn RT, Williams M, Miller DC, Douglas PS, Leon MB. Predictors of mortality and outcomes of therapy in low‐flow severe aortic stenosis: a Placement of Aortic Transcatheter Valves (PARTNER) trial analysis. Circulation. 2013;127:2316–2326. - PubMed
    1. Ding WH, Lam YY, Duncan A, Li W, Lim E, Kaya MG, Chung R, Pepper JR, Henein MY. Predictors of survival after aortic valve replacement in patients with low‐flow and high‐gradient aortic stenosis. Eur J Heart Fail. 2009;11:897–902. - PubMed
    1. Halkos ME, Chen EP, Sarin EL, Kilgo P, Thourani VH, Lattouf OM, Vega JD, Morris CD, Vassiliades T, Cooper WA, Guyton RA, Puskas JD. Aortic valve replacement for aortic stenosis in patients with left ventricular dysfunction. Ann Thorac Surg. 2009;88:746–751. - PubMed
    1. Kuwaki K, Amano A, Inaba H, Yamamoto T, Matsumura T, Dohi S, Matsushita S. Predictors of early and mid‐term results in contemporary aortic valve replacement for aortic stenosis. J Card Surg. 2012;27:139–145. - PubMed
    1. Wendt D, Osswald BR, Kayser K, Thielmann M, Tossios P, Massoudy P, Kamler M, Jakob H. Society of Thoracic Surgeons score is superior to the EuroSCORE determining mortality in high risk patients undergoing isolated aortic valve replacement. Ann Thorac Surg. 2009;88:468–474. - PubMed

MeSH terms

LinkOut - more resources